Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference
SLN ("Silence" or the "Company"), a global clinical stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced the Company will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday,
Zealand Pharma to participate in the Jefferies London Healthcare Conference
No. 11 / 2024Zealand Pharma to participate in the Jefferies London Healthcare ConferenceCopenhagen, Denmark, November 13, 2024 –
Orchestra BioMed to Present at Jefferies London Healthcare Conference
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its participation in the upcoming Jefferies London Healthcare Conference. The event, taking place in London, UK, from November
Zoetis to Participate in Jefferies London Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 3:00 p.
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options.
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference
A webcast of the fireside chat will be accessible via the “Events” section of Monte Rosa’s website at ir.monterosatx.com, and an archived version will be made available for 30 days following the presentation.
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients
SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on-one investor meetings at the Jefferies London Healthcare Conference to be held November 19-21,
Business Insider5h
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
AC Immune to Present at the Jefferies 2024 London Healthcare Conference Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company ...
Yahoo Finance20h
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that ...
Business Wire7d
BeiGene to Present at the Jefferies London Healthcare Conference
today announced it will participate in the Jefferies London Healthcare Conference on November 20, 2024, with a fireside chat at 2:30 p.m. GMT. The live webcast of this event can be accessed from ...
Nasdaq7d
Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference
THE WOODLANDS, Texas, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies London Global Healthcare Conference.
Yahoo Finance28m
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference
plans to participate in a fireside chat during the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, ...
TMCnet8h
Oculis to Present at the Stifel 2024 Healthcare Conference
Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be present at the ...